​​​
  1. Lupin’s Q2 net beats analysts’ expectations, sales fall short

Lupin’s Q2 net beats analysts’ expectations, sales fall short

Lupin’s second-quarter profit beat analyst estimates, However, sales fell...

By: | Published: October 29, 2014 1:00 AM

Lupin’s second-quarter profit beat analyst estimates, However, sales fell a bit short of Street expectations. The company attributed the muted sales growth to antibiotics being a significant proportion of its product mix — which witnesses a pickup during the flu season in the US from October to March.
It reported a profit of R630 crore on sales of R3,116.8 crore for the quarter ended September 30 against the  analysts’ expectation of a profit of R580 crore on sales of R3,330 crore, according to a Bloomberg poll.
Sales grew 18.4% y-o-y while profit registered an increase of 55.1%.
Manufacturing and other expenses reduced 3.7% y-o-y to 296.7% of net sales and stood at R832.2 crore for the quarter.

Get live Stock Prices from BSE and NSE and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Go to Top